HEN1 Activators
Chemical activators of HEN1 can initiate a cascade of intracellular events that result in the upregulation and functional activation of this protein. Forskolin, isoproterenol, epinephrine, and glucagon all work through the adenylyl cyclase-cAMP-CREB pathway. Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels and thereby activating CREB, which can enhance NHLH1 gene transcription, ultimately leading to increased HEN1 activity. Similarly, isoproterenol, a beta-adrenergic agonist, and epinephrine engage adrenergic receptors to elevate cAMP levels, while glucagon activates its receptor to produce the same effect. The actions of these chemicals converge on the activation of CREB, a transcription factor that can upregulate the NHLH1 gene, thereby activating the HEN1 protein. Dibutyryl-cAMP, a synthetic cAMP analog, bypasses cell surface receptors and directly activates CREB, following a similar activation route. Prostaglandin E2 (PGE2) works through its own receptors to elevate cAMP levels, contributing to this common signaling pathway favoring HEN1 activation.
Further supporting the cAMP pathway, rolipram and IBMX increase cAMP levels by inhibiting phosphodiesterases, which normally degrade cAMP. The resulting CREB activation can lead to the enhancement of HEN1 protein activity. Retinoic acid, through its nuclear receptors, can regulate gene expression and may influence the transcription of NHLH1, leading to HEN1 activation. Lithium chloride's inhibition of GSK-3 can result in the stabilization of transcription factors that regulate NHLH1 gene expression, and thus HEN1 activation. Leptin, though primarily associated with energy homeostasis, can exert influence on neuronal gene expression, which may include effects on NHLH1 transcription. Insulin, via the PI3K/Akt pathway, has the potential to modulate gene expression, including that of NHLH1, leading to an increase in HEN1 activity. These chemicals, through their respective pathways, converge on the transcriptional activation of NHLH1, translating into higher levels of HEN1 protein activity within cellular contexts.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cyclic AMP (cAMP) levels within cells. Elevated cAMP can enhance the activity of cAMP response element-binding protein (CREB), which can then increase the transcription of genes including NHLH1, leading to functional activation of the HEN1 protein. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that stimulates adenylyl cyclase via G protein-coupled receptor signaling, raising intracellular cAMP levels. This can lead to activation of CREB and subsequent upregulation of NHLH1 gene transcription, thus enhancing the functional activity of HEN1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. By inhibiting PDE4, rolipram increases cAMP levels, which may activate CREB and promote transcription of genes such as NHLH1, potentially leading to increased functional activity of HEN1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased levels of cAMP and cGMP. The elevation of cAMP can activate CREB, which may enhance the transcription of the NHLH1 gene, potentially leading to higher functional activity of the HEN1 protein. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages adrenergic receptors, leading to increased cAMP levels through adenylyl cyclase activation. This surge in cAMP can lead to CREB activation, which may upregulate NHLH1 gene expression and thus increase HEN1 protein activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors to regulate gene expression. It can influence the transcription of various genes, including potentially the NHLH1 gene, which may lead to the functional activation of the HEN1 protein. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit glycogen synthase kinase 3 (GSK-3), which may result in the stabilization and activation of transcription factors that upregulate gene expression, including that of NHLH1, consequently enhancing HEN1 protein activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP. It can mimic the action of cAMP by activating CREB, which could lead to the transcriptional upregulation of the NHLH1 gene, thus potentially increasing the functional activity of HEN1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with its EP receptors, which can lead to increased cAMP levels in cells. This rise in cAMP can lead to CREB activation and possibly an increase in NHLH1 gene transcription, which in turn might elevate the functional activity of the HEN1 protein. | ||||||
Ob (hBA-147) | sc-4912 | 1000 µg | $258.00 | 1 | ||
Also called Leptin, this compound can influence neuronal activity and gene expression. While not directly linked to HEN1 activation, leptin's influence on neuronal gene regulation may extend to the upregulation of the NHLH1 gene, leading to increased functional activity of HEN1. | ||||||